666 related articles for article (PubMed ID: 28440473)
1. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
2. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
3. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.
Han J; Fu R; Chen C; Cheng X; Guo T; Huangfu L; Li X; Du H; Xing X; Ji J
Int J Biol Sci; 2021; 17(11):2841-2852. PubMed ID: 34345211
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
5. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
6. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
[TBL] [Abstract][Full Text] [Related]
7. High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.
Chen Y; Liu J; Wang W; Xiang L; Wang J; Liu S; Zhou H; Guo Z
Oncol Rep; 2018 Apr; 39(4):1693-1701. PubMed ID: 29484423
[TBL] [Abstract][Full Text] [Related]
8. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
[TBL] [Abstract][Full Text] [Related]
10. The effect and clinical significance of FN1 expression on biological functions of gastric cancer cells.
Zhou Y; Cao G; Cai H; Huang H; Zhu X
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):191-198. PubMed ID: 33040835
[TBL] [Abstract][Full Text] [Related]
11. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
[TBL] [Abstract][Full Text] [Related]
12. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.
Cao JM; Li GZ; Han M; Xu HL; Huang KM
Biomed Pharmacother; 2017 Sep; 93():554-560. PubMed ID: 28686969
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
[TBL] [Abstract][Full Text] [Related]
15. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
[TBL] [Abstract][Full Text] [Related]
17. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
18. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.
Gao C; Guo X; Xue A; Ruan Y; Wang H; Gao X
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):310-319. PubMed ID: 32147684
[TBL] [Abstract][Full Text] [Related]
19. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
20. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients.
Liu JY; Jiang L; Liu JJ; He T; Cui YH; Qian F; Yu PW
Sci Rep; 2018 Aug; 8(1):11955. PubMed ID: 30097586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]